CVE-2026-93891: IBM TRIRIGA Application Platform XXE injection

CVE-2026-93891 · Severity: high · CVSS 7.6 · Published 2026-10-12

IBM TRIRIGA Application Platform is an enterprise application used for real estate and facilities management. An authenticated attacker could exploit an XML external entity (XXE) injection flaw to extract sensitive information from the system, such as configuration data or internal files.

Technologies: IBM Tririga Application Platform. Vendors: IBM.

Quick answers

Is CVE-2026-93891 exploited in the wild?
No. Junglewise Threat Intelligence has no report of CVE-2026-93891 being exploited in the wild.
How severe is CVE-2026-93891?
High severity, with a CVSS score of 7.6, published 12 October 2026.
Which products and versions are affected?
IBM Tririga Application Platform 5.0.0 through 5.0.8.
Is there a fix for CVE-2026-93891?
No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
How is CVE-2026-93891 attacked?
It is attacked over the network.
Am I affected by CVE-2026-93891?
Check whether you run IBM Tririga Application Platform at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.

Technical details

An XXE injection flaw in IBM TRIRIGA Application Platform versions 5.0.0 through 5.0.8 allows an authenticated remote attacker to read arbitrary files or internal XML content on the server. The vulnerability exists in XML parsing functionality that does not properly disable external entity resolution. Successful exploitation requires valid authentication credentials and network access to the vulnerable application.

Affected products

  • IBM TRIRIGA Application Platform 5.0.0 through 5.0.8

Timeline

  • 2026-10-12: disclosed

References

This page as Markdown. Free to reuse under CC BY 4.0 with a link back.